课题基金 / 基金详情

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA
睡眠呼吸暂停患者服用罗格列酮
批准号：
7625761
负责人：
ALEXANDROS N VGONTZAS
金额：
$5.74万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-04-01 至 2008-03-31
来源：
https://reporter.nih.gov/project-details/7625761
关键词：
Central obesityClinicalComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionInsulin ResistanceObstructive Sleep ApneaPatientsResearchResearch PersonnelResourcesSeveritiesSleep Apnea SyndromesSourceUnited States National Institutes of Healthrosiglitazone

项目摘要

项目成果

ALEXANDROS N VGONTZAS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的基本假设是胰岛素抵抗/内脏肥胖是阻塞性睡眠呼吸暂停的致病因素，也是其临床严重性的主要决定因素。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary hypothesis of this study is that insulin resistance/visceral obesity is a pathogenetic factor in obstructive sleep apnea and is a primary determinant of its clinical severity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data